MedPath

To know the effect of RUMA Spray in Acute Musculoskeletal Pain and Acute Sports Injury Pai

Phase 2
Conditions
Health Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissue
Registration Number
CTRI/2021/04/032710
Lead Sponsor
The Himalaya Drug Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Subjects of either gender aged >=18 - <=65 years.

2.Subjects with Grade I and Grade II muscular sprains and joint pain.

3.Subjects suffering from Common musculoskeletal conditions - Back ache, joints pain (Wrist, elbow, shoulder, ankle, Knee, neck pain, sprains and strains / Sports and traumatic injuries.

4.Subjects willing to sign informed consent and follow with the schedule.

5.Subjects who have not participated in similar kind of study in last 4 weeks.

Exclusion Criteria

1.subjects suffering from auto-immune disorders, spastic disorders, genetic disorders and severe traumatic conditions.

2.Any evidence or history of hypersensitivity to any of the components in the RUMA Spray

3.Any known skin disorder or presence of open wounds.

4.subjects who are taking any additional topical therapy or systemic NSAIDs.

5.Clinical diagnosis of bruises, trauma, muscle damage.

6.subjects with raw wounds, sutures, fractures and hematoma.

7.Pregnant or lactating women/women not willing to follow adequate standard contraceptive measures.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath